Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Lrfn3 (leucine rich repeat and fibronectin type III domain containing 3) Rattus norvegicus
Analyze
Symbol: Lrfn3
Name: leucine rich repeat and fibronectin type III domain containing 3
Description: Involved in regulation of presynapse assembly; regulation of synaptic membrane adhesion; and synaptic membrane adhesion. Localizes to the glutamatergic synapse; integral component of postsynaptic density membrane; and integral component of presynaptic active zone membrane. Orthologous to human LRFN3 (leucine rich repeat and fibronectin type III domain containing 3); INTERACTS WITH 2,4-dinitrotoluene; 4-amino-2,6-dinitrotoluene; bisphenol A.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: leucine-rich repeat and fibronectin type-III domain-containing protein 3; LOC308495; Salm4; synaptic adhesion-like molecule 4
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0188,819,439 - 88,827,002 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.0189,975,457 - 89,983,028 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4185,308,917 - 85,314,395 (-)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.1185,387,026 - 85,394,405 (-)NCBI
Celera179,989,362 - 79,994,840 (-)NCBICelera
Cytogenetic Map1q21NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


References - curated
References - uncurated
RGD Disease Portals

Genomics

Comparative Map Data
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome

Strain Variation

Strain Sequence Variants (Rnor 5.0)
Damaging Variants

Additional Information

External Database Links
Nomenclature History
 
More on Lrfn3
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1305567
Created: 2005-01-12
Species: Rattus norvegicus
Last Modified: 2019-08-20
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.